R.M. Rivas-Landeros, Microbiology Laboratory, Hospital General de Tijuana, Tijuana Baja-California, Mexico. M.L. Volker-Soberanes, Microbiology Laboratory, Hospital General de Tijuana, Tijuana Baja-California, Mexico.

Classical vaccines rely on the use of whole killed or attenuated pathogens. Today, research is focused on the development

selleckchem of subunit vaccines because they are better defined, easier to produce and safer. Vaccines are manufactured on the basis of well characterized antigens, such as recombinant proteins and peptides. However, due to their synthetic nature, their immune response is often weak, which is largely related to the inability of the antigens to induce maturation of dendritic cells (DCs), the primary antigen-presenting cells (APCs) that react to foreign pathogens and

trigger the immune response [Moser and Leo, 2010; Reed et al. 2013]. The immune system is composed of the innate and the adaptive systems. The first is responsible for first-line host defense, rapidly recognizing and responding to foreign pathogens. The complement system and phagocytic cells belong to this defense system which depends on pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs). Toll-like receptors (TLRs) present on APCs are the receptors for pathogens containing PAMPs. TLR activation is the hallmark of innate immune response. The second defense line, the adaptive immune system, mounts specific responses against molecular determinants

on pathogenic agents. These responses are initiated by antigen-mediated triggering of T cells, the CD4+ T-helper (TH) cells, the CD8+ cytotoxic T lymphocytes (CTLs) and B lymphocytes carrying antigen-specific surface receptors. TH cells have subpopulations, of which TH1 and TH2 are the most important [Nordly et al. 2009; Kawai and Akira, 2010]. The diverse mechanisms by which nanoparticles induce immune responses are summarized in Figure 1. Activation of PRRs triggers the initiation of the innate immune response. Activated CTLs recognize peptides bound to the major histocompatibility complex class I and II molecules (MHC-I, MHC-II), which express antigenic peptides on APCs and bind to T cells via the T-cell receptor. A costimulatory Dacomitinib signal is needed for full CTL and TH cell activation which differentiate into TH1 or TH2 and other T-helper lineages that produce cytokines. TH cells provide help to antigen-specific B cells, resulting in antibody production [Lin et al. 2010; Chen and Flies, 2013]. Each invasion of a foreign antigen requires activation of a specific type of adaptive immune response for efficient control and elimination. Thus, vaccine formulations should be designed rationally to induce specific protective responses.